These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29354551)

  • 1. Community pharmacy COPD services: what do researchers and policy makers need to know?
    Twigg MJ; Wright DJ
    Integr Pharm Res Pract; 2017; 6():53-59. PubMed ID: 29354551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary health care policy and vision for community pharmacy and pharmacists in Australia.
    Dineen-Griffin S; Benrimoj SI; Garcia-Cardenas V
    Pharm Pract (Granada); 2020; 18(2):1967. PubMed ID: 32477437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mixed methods analysis of community pharmacists' perspectives on delivering COPD screening service to guide future implementation.
    Fathima M; Saini B; Foster JM; Armour CL
    Res Social Adm Pharm; 2019 Jun; 15(6):662-672. PubMed ID: 30131254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A stakeholder co-design approach for developing a community pharmacy service to enhance screening and management of atrial fibrillation.
    Sabater-Hernández D; Tudball J; Ferguson C; Franco-Trigo L; Hossain LN; Benrimoj SI
    BMC Health Serv Res; 2018 Feb; 18(1):145. PubMed ID: 29486758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
    Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
    Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are pharmacists reducing COPD'S impact through smoking cessation and assessing inhaled steroid use?
    Verma A; Harrison A; Torun P; Vestbo J; Edwards R; Thornton J
    Respir Med; 2012 Feb; 106(2):230-4. PubMed ID: 21899999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing national implementation of innovations within community pharmacy: a systematic review applying the Consolidated Framework for Implementation Research.
    Weir NM; Newham R; Dunlop E; Bennie M
    Implement Sci; 2019 Mar; 14(1):21. PubMed ID: 30832698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist-managed chronic obstructive pulmonary disease screening in a community setting.
    Fuller L; Conrad WF; Heaton PC; Panos R; Eschenbacher W; Frede SM
    J Am Pharm Assoc (2003); 2012; 52(5):e59-66. PubMed ID: 22975798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of a multi-site community pharmacy-based chronic obstructive pulmonary disease support service.
    Wright D; Twigg M; Barton G; Thornley T; Kerr C
    Int J Pharm Pract; 2015 Feb; 23(1):36-43. PubMed ID: 25409898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From community pharmacy to healthy living pharmacy: positive early experiences from Portsmouth, England.
    Brown D; Portlock J; Rutter P; Nazar Z
    Res Social Adm Pharm; 2014; 10(1):72-87. PubMed ID: 23731701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding professional pharmacy services in European community setting: Is it cost-effective? A systematic review for health policy considerations.
    Perraudin C; Bugnon O; Pelletier-Fleury N
    Health Policy; 2016 Dec; 120(12):1350-1362. PubMed ID: 28228230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Best Practices: Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25491911
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.